Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015)
Prothena Corp Public's (PRTA) quarterly Current Deferred Tax Assets came in at $174000.0 in Q3 2015, up 95.51% year-on-year from $89000.0 in Q3 2014, and up 5.45% quarter-over-quarter from $165000.0 in Q2 2015.
Prothena Corp Public (PRTA) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends
Prothena Corp Public's Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $174000.0 for Q3 2015.
- On a quarterly basis, Current Deferred Tax Assets rose 95.51% year-over-year to $174000.0 in Q3 2015; TTM through Sep 2015 was $174000.0, a 95.51% increase from a year earlier, with the FY2014 full-year figure at $167000.0, up 106.17% from the prior year.
- Current Deferred Tax Assets rose to $174000.0 in Q3 2015 per PRTA's latest filing, from $165000.0 in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $267000.0 in Q3 2013 and bottomed at $73000.0 in Q4 2012.
- The 4-year median for Current Deferred Tax Assets is $85500.0 (2014), against an average of $123666.7.
- Across the five-year window, Current Deferred Tax Assets slumped 66.67% in 2014 and surged 111.69% in 2015, its largest moves.
- Year by year, Current Deferred Tax Assets stood at $73000.0 in 2012, then gained by 10.96% to $81000.0 in 2013, then surged by 106.17% to $167000.0 in 2014, then grew by 4.19% to $174000.0 in 2015.
- Per Business Quant, the three latest PRTA Current Deferred Tax Assets figures stand at $174000.0 (Q3 2015), $165000.0 (Q2 2015), and $163000.0 (Q1 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 174,000.00 |
| Sep 30, 2015 | 174,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Mar 31, 2015 | 163,000.00 |
| Mar 31, 2015 | 163,000.00 |
| Dec 31, 2014 | 167,000.00 |
| Dec 31, 2014 | 167,000.00 |
| Sep 30, 2014 | 89,000.00 |
| Sep 30, 2014 | 89,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Mar 31, 2014 | 77,000.00 |
| Mar 31, 2014 | 77,000.00 |
| Dec 31, 2013 | 81,000.00 |
| Dec 31, 2013 | 81,000.00 |
| Sep 30, 2013 | 267,000.00 |
| Sep 30, 2013 | 267,000.00 |
| Jun 30, 2013 | 73,000.00 |
| Jun 30, 2013 | 73,000.00 |